San Diego-based Dexcom expects its deal to buy Nutrisense for an undisclosed amount in the coming weeks. With the acquisition, the continuous glucose monitor (CGM) maker plans to further expand its ability to support users beyond glucose data alone.
Nutrisense’s offerings enable Dexcom to incorporate access to registered dietitians, personalized nutrition guidance and behavior-change support. The company says its acquisition strengthens its ability to provide personal nutrition education and guidance linking food choices to glucose responses.
Additionally, at the American Diabetes Association’s Scientific Sessions (ADA 2026) in New Orleans, which begins tomorrow, Dexcom plans to offer select users the opportunity for early access to a reimagined app experience for its Stelo over-the-counter CGM.
Get the full story at our sister site, Drug Delivery Business News.
